don’t understand clearly one person had to sell.
strong result! Clearly looks like they will outperform their market guidance.
EBITDA solid, Revenue Solid and a small NPAT which I was not expecting given the rollout of the new CBI contract thought there would be more one off costs and increased depreciation.
want to see additional marketing spend to get this story in front of new eyes!
- Forums
- ASX - By Stock
- FND
- Ann: Positive half year results following strong growth in India
Ann: Positive half year results following strong growth in India, page-3
Featured News
Add FND (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.50 |
Change
0.680(9.97%) |
Mkt cap ! $367.6M |
Open | High | Low | Value | Volume |
$7.40 | $7.70 | $7.10 | $3.240M | 436.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 170 | $7.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.50 | 10946 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 216 | 7.430 |
1 | 1700 | 7.400 |
1 | 136 | 7.350 |
1 | 5000 | 7.340 |
1 | 5000 | 7.320 |
Price($) | Vol. | No. |
---|---|---|
7.500 | 4906 | 1 |
7.620 | 200 | 1 |
7.740 | 14 | 1 |
7.750 | 9999 | 2 |
7.800 | 2000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
FND (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online